drugset / Trial / NCT00688935

Young Blind Child Melatonin Treatment Study

NCT00688935

Terminated 9 enrolled Oregon Health and Science University
Non-randomizedSingle-groupSingle-blindDiagnostic

Summary

The primary goal of this study is to identify the presence of desynchronized circadian rhythms in 25 children by measuring melatonin secretion in serial blood or saliva samples, and to rule out any primary sleep disorders.

Timeline

Start
2005-01
Primary completion
2015-05
Completion
2015-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Melatonin Small molecule 0.1 mg
Subject Melatonin Small molecule 3 mg

Indications